Study S000517

Assessment of Gastric Function Using Body Surface Gastric Mapping in Patients on Semaglutide (Ozempic)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT06401746
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 9
Start: 2024-05-01
Primary completion: 2025-03-13
Lead sponsor: University of Western Sydney
Conditions: Semaglutide-Induced Gastric Motility; Gastroparesis
Interventions: DEVICE:Gastric Alimetry
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Change in Overall BSGM BMI-adjusted Amplitude on Drug Compared to Baseline. [Baseline, Month 2 (On Drug)]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0014766	Semaglutide Induces Changes in Gastric Electrical Activity in Patients With Overweight and Obesity: A Pilot Study. Abraham R, Journal of neurogastroenterology and motility	2026	Other	PMID 41952406 DOI	registry reference RESULT:41952406